NASDAQ:PRE Prenetics Global (PRE) Stock Price, News & Analysis $18.74 -0.68 (-3.50%) Closing price 07/24/2026 04:00 PM EasternExtended Trading$19.14 +0.40 (+2.13%) As of 07/24/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Prenetics Global Stock (NASDAQ:PRE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Prenetics Global alerts:Sign Up Key Stats Today's Range$18.51▼$19.9950-Day Range$14.54▼$22.0652-Week Range$7.18▼$23.63Volume149,200 shsAverage Volume250,650 shsMarket Capitalization$316.14 millionP/E RatioN/ADividend YieldN/APrice Target$34.25Consensus RatingModerate Buy Company Overview Prenetics Global (NASDAQ: PRE) is a molecular diagnostics and genetic testing company that delivers a broad range of laboratory and at-home testing solutions. The company’s core offerings include next-generation sequencing (NGS) panels for hereditary health risks, pharmacogenomic reports to guide medication choices, and comprehensive consumer DNA testing services. In addition to genetic insights, Prenetics provides infectious disease diagnostics—most notably real-time PCR testing for pathogens such as SARS-CoV-2—through an integrated platform that combines sample collection, laboratory processing and digital reporting. Serving both business-to-consumer and business-to-business markets, Prenetics operates a network of laboratories and service centers across Asia Pacific, Europe, the Middle East and North America. Its consumer brand, CircleDNA, offers a direct-to-consumer genetic testing kit that reports on wellness traits, nutrition, fitness and inherited disease risks. On the corporate side, the company partners with healthcare providers, sports organizations and governments to deploy large-scale testing programs and personalized health initiatives. Prenetics also supports telehealth services, enabling remote consultations based on genetic and diagnostic results. Founded in 2014 and headquartered in Hong Kong, Prenetics was established by CEO Danny Yeung, a tech entrepreneur with a background in fintech and digital platforms. Under his leadership, the company has expanded through strategic partnerships and investments in laboratory automation and data analytics. Prenetics completed a public listing on the Nasdaq in 2022, positioning itself to accelerate global market expansion and further develop its precision health offerings.AI Generated. May Contain Errors. Read More Prenetics Global Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScorePRE MarketRank™: Prenetics Global scored higher than 44% of companies evaluated by MarketBeat, and ranked 626th out of 836 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingPrenetics Global has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 4 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialPrenetics Global has a consensus price target of $34.25, representing about 82.8% upside from its current price of $18.74.Amount of Analyst CoveragePrenetics Global has only been the subject of 2 research reports in the past 90 days.Read more about Prenetics Global's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Prenetics Global is -4.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Prenetics Global is -4.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPrenetics Global has a P/B Ratio of 2.02. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Prenetics Global's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.28% of the float of Prenetics Global has been sold short.Short Interest Ratio / Days to CoverPrenetics Global has a short interest ratio ("days to cover") of 2.48, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Prenetics Global has recently increased by 19.42%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPrenetics Global does not currently pay a dividend.Dividend GrowthPrenetics Global does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.41 News SentimentPrenetics Global has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Prenetics Global this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for PRE on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Prenetics Global insiders have not sold or bought any company stock.Percentage Held by Insiders7.80% of the stock of Prenetics Global is held by insiders.Percentage Held by Institutions25.01% of the stock of Prenetics Global is held by institutions.Read more about Prenetics Global's insider trading history. Receive PRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prenetics Global and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRE Stock News HeadlinesWall Street Zen Downgrades Prenetics Global (NASDAQ:PRE) to SellJuly 25 at 1:30 AM | americanbankingnews.comPrenetics Global: Path To Profitability On Course With Financing DealJuly 24 at 12:48 PM | seekingalpha.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.July 25 at 1:00 AM | Chaikin Analytics (Ad)Sidoti Estimates Prenetics Global's Q3 Earnings (NASDAQ:PRE)July 19, 2026 | americanbankingnews.comPrenetics’ IM8 Secures $1 Billion Non-Dilutive Financing as Revenue Outlook RisesJuly 17, 2026 | theglobeandmail.comPRE Continues to Exceed Expectations and Receive Preferential FinancingJuly 17, 2026 | msn.comPrenetics CEO on securing $1 billion funding to fuel subsidiary IM8's growthJuly 17, 2026 | msn.comPrenetics Global Limited (NASDAQ:PRE) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 17, 2026 | americanbankingnews.comSee More Headlines PRE Stock Analysis - Frequently Asked Questions How have PRE shares performed this year? Prenetics Global's stock was trading at $15.75 on January 1st, 2026. Since then, PRE shares have increased by 19.0% and is now trading at $18.74. How were Prenetics Global's earnings last quarter? Prenetics Global Limited (NASDAQ:PRE) posted its quarterly earnings data on Wednesday, June, 10th. The company reported ($0.56) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.49) by $0.07. The company had revenue of $35.95 million for the quarter, compared to analyst estimates of $36 million. Prenetics Global had a negative net margin of 62.45% and a negative trailing twelve-month return on equity of 20.33%. Read the conference call transcript. When did Prenetics Global's stock split? Prenetics Global's stock reverse split on Tuesday, November 14th 2023.The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, November 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. Is Prenetics Global doing a stock buyback? Prenetics Global's Board of Directors initiated a stock buyback program on Friday, March 6th 2026, which permits the company to buy back $40,000,000 in shares, according to EventVestor. This means that the company could purchase up to 15.8% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued. How do I buy shares of Prenetics Global? Shares of PRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Prenetics Global own? Based on aggregate information from My MarketBeat watchlists, some other companies that Prenetics Global investors own include Arista Networks (ANET), Adobe (ADBE), Broadcom (AVGO), NVIDIA (NVDA), Intuit (INTU), Arch Capital Group (ACGL) and Celestica (CLS). Company Calendar Last Earnings6/10/2026Today7/25/2026Next Earnings (Estimated)9/11/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:PRE CIK1876431 Webwww.prenetics.com Phone852-2210-9588FaxN/AEmployees1Year Founded2009Price Target and Rating Average Price Target for Prenetics Global$34.25 High Price Target$40.00 Low Price Target$29.00 Potential Upside/Downside+82.8%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($4.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$37.71 million Net Margins-62.45% Pretax Margin-50.52% Return on Equity-20.33% Return on Assets-15.42% Debt Debt-to-Equity RatioN/A Current Ratio5.15 Quick Ratio4.60 Sales & Book Value Annual Sales$92.39 million Price / Sales3.42 Cash FlowN/A Price / Cash FlowN/A Book Value$9.27 per share Price / Book2.02Miscellaneous Outstanding Shares16,870,000Free Float15,558,000Market Cap$316.14 million OptionableNot Optionable Beta0.26 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:PRE) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored“The unseen winner of the AI race” is not SpaceXMarc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...Chaikin Analytics | SponsoredBlackRock, JPMorgan, and Goldman are all stock piling the same asset… are you?BlackRock, JPMorgan, Goldman Sachs, Fidelity, ARK Invest and Andreessen Horowitz are all buying the same asset...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prenetics Global Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Prenetics Global With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRE Stock Alerts